Literature DB >> 17463170

Role of CD28 in fatal autoimmune disorder in scurfy mice.

Nagendra Singh1, Phillip R Chandler, Yoichi Seki, Babak Baban, Mayuko Takezaki, David J Kahler, David H Munn, Christian P Larsen, Andrew L Mellor, Makio Iwashima.   

Abstract

Scurfy mice develop CD4 T-cell-mediated lymphoproliferative disease leading to death within 4 weeks of age. The scurfy mutation causes loss of function of the foxp3 gene (foxp3(sf)), which is essential for development and maintenance of naturally occurring regulatory CD4 T cells (nTregs). In humans, mutations of the foxp3 gene cause immune dysregulation, polyendocrinopathy, enteropathy, and X-linked syndrome (IPEX). In most patients with IPEX and also in scurfy mice, T cells show hyperreactivity and levels of Th1- and Th2-associated cytokines are substantially elevated. We report that removal of CD28 expression rescued scurfy mice from early death. Longer-term surviving CD28-deficient scurfy mice still had lymphoproliferative disorder, but their CD4 T cells showed decreased interferon-gamma and no sign of interleukin-4 or interleukin-10 hyperproduction. Furthermore, injection of CTLA4-Ig to block CD28-B7 interactions substantially improved the survival of scurfy mice by blocking effector T-cell differentiation. These data support the hypothesis that CD28-B7 interactions play a critical role in the etiology of lethal autoimmune disease in scurfy mice by stimulating the differentiation of antigen-activated naive T cells into effector T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17463170      PMCID: PMC1939901          DOI: 10.1182/blood-2006-10-054585

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.

Authors:  D A Mandelbrot; M A Oosterwegel; K Shimizu; A Yamada; G J Freeman; R N Mitchell; M H Sayegh; A H Sharpe
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Functional responses and costimulator dependence of memory CD4+ T cells.

Authors:  C A London; M P Lodge; A K Abbas
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

3.  The immunological synapse and CD28-CD80 interactions.

Authors:  S K Bromley; A Iaboni; S J Davis; A Whitty; J M Green; A S Shaw; A Weiss; M L Dustin
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

4.  Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation.

Authors:  O Baud; O Goulet; D Canioni; F Le Deist; I Radford; D Rieu; S Dupuis-Girod; N Cerf-Bensussan; M Cavazzana-Calvo; N Brousse; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

Review 5.  The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system.

Authors:  D E Anderson; A H Sharpe; D A Hafler
Journal:  Curr Opin Immunol       Date:  1999-12       Impact factor: 7.486

Review 6.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.

Authors:  B Salomon; J A Bluestone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 7.  The role of costimulation in autoimmune demyelination.

Authors:  M K Racke; R B Ratts; L Arredondo; P J Perrin; A Lovett-Racke
Journal:  J Neuroimmunol       Date:  2000-07-24       Impact factor: 3.478

8.  Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis.

Authors:  Yutaka Matsui; Manabu Inobe; Hiroshi Okamoto; Satoru Chiba; Toshihiro Shimizu; Akira Kitabatake; Toshimitsu Uede
Journal:  J Mol Cell Cardiol       Date:  2002-03       Impact factor: 5.000

Review 9.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

10.  Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

Authors:  T Takahashi; T Tagami; S Yamazaki; T Uede; J Shimizu; N Sakaguchi; T W Mak; S Sakaguchi
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  16 in total

Review 1.  Genetic control of the inflammatory T-cell response in regulatory T-cell deficient scurfy mice.

Authors:  Rahul Sharma; Shyr-Te Ju
Journal:  Clin Immunol       Date:  2010-05-08       Impact factor: 3.969

2.  Unregulated antigen-presenting cell activation by T cells breaks self tolerance.

Authors:  Jaeu Yi; Jisun Jung; Sung-Wook Hong; Jun Young Lee; Daehee Han; Kwang Soon Kim; Jonathan Sprent; Charles D Surh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-31       Impact factor: 11.205

3.  Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function.

Authors:  Deepali V Sawant; Sarita Sehra; Evelyn T Nguyen; Rohit Jadhav; Kate Englert; Ryo Shinnakasu; Giao Hangoc; Hal E Broxmeyer; Toshinori Nakayama; Narayanan B Perumal; Mark H Kaplan; Alexander L Dent
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

4.  Foxp3⁺ regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis.

Authors:  Lei Tian; John A Altin; Lydia E Makaroff; Dean Franckaert; Matthew C Cook; Christopher C Goodnow; James Dooley; Adrian Liston
Journal:  Blood       Date:  2011-06-28       Impact factor: 22.113

Review 5.  Immunologic endocrine disorders.

Authors:  Aaron W Michels; George S Eisenbarth
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

6.  B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells.

Authors:  James M Ertelt; Esra Z Buyukbasaran; Tony T Jiang; Jared H Rowe; Lijun Xin; Sing Sing Way
Journal:  J Leukoc Biol       Date:  2013-06-06       Impact factor: 4.962

Review 7.  Autoimmune polyglandular syndromes.

Authors:  Aaron W Michels; Peter A Gottlieb
Journal:  Nat Rev Endocrinol       Date:  2010-03-23       Impact factor: 43.330

8.  B cells are critical for autoimmune pathology in Scurfy mice.

Authors:  Susanne Aschermann; Christian H K Lehmann; Sidonia Mihai; Georg Schett; Diana Dudziak; Falk Nimmerjahn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-05       Impact factor: 11.205

9.  Commensal microbes drive intestinal inflammation by IL-17-producing CD4+ T cells through ICOSL and OX40L costimulation in the absence of B7-1 and B7-2.

Authors:  Lijun Xin; Tony T Jiang; Vandana Chaturvedi; Jeremy M Kinder; James M Ertelt; Jared H Rowe; Kris A Steinbrecher; Sing Sing Way
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

10.  Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice.

Authors:  Fabrina Gaspal; David Withers; Manoj Saini; Vasileios Bekiaris; Fiona M McConnell; Andrea White; Mahmood Khan; Hideo Yagita; Lucy S K Walker; Graham Anderson; Peter J L Lane
Journal:  J Exp Med       Date:  2011-07-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.